GBT Trademark

Trademark Overview

On Tuesday, November 21, 2017, a trademark application was filed for GBT with the United States Patent and Trademark Office. The USPTO has given the GBT trademark a serial number of 87693424. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by Global Blood Therapeutics, Inc.. The GBT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services
gbt

General Information

Serial Number87693424
Word MarkGBT
Filing DateTuesday, November 21, 2017
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6164470
Registration DateTuesday, September 29, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements

Description of MarkThe mark consists of the letters "GBT" followed by three connected hexagons positioned on the top right corner.
Pseudo MarkGLOBAL BLOOD THERAPEUTICS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 4, 2017
Primary Code042
First Use Anywhere DateSaturday, November 30, 2019
First Use In Commerce DateSaturday, November 30, 2019

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, November 24, 2017NEW APPLICATION ENTERED
Monday, December 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 5, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 27, 2017ASSIGNED TO EXAMINER
Wednesday, December 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 25, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018SOU EXTENSION 1 FILED
Tuesday, September 25, 2018SOU EXTENSION 1 GRANTED
Thursday, September 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019SOU TEAS EXTENSION RECEIVED
Friday, March 8, 2019SOU EXTENSION 2 FILED
Friday, March 8, 2019SOU EXTENSION 2 GRANTED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, September 25, 2019SOU EXTENSION 3 FILED
Wednesday, September 25, 2019SOU EXTENSION 3 GRANTED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, February 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 4, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, March 24, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 24, 2020SOU EXTENSION 4 FILED
Tuesday, March 24, 2020SOU EXTENSION 4 GRANTED
Thursday, March 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 5, 2020CORRECTED NOA E-MAILED
Friday, August 14, 2020TEAS STATEMENT OF USE RECEIVED
Friday, August 14, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 14, 2020SOU EXTENSION 5 FILED
Tuesday, August 18, 2020SOU EXTENSION 5 GRANTED
Friday, August 14, 2020USE AMENDMENT FILED
Tuesday, August 18, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 29, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

services development research pharmaceutical